• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

PF-06882961 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5753677

PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
PF-06882961, Inhibitor
Full Product Name
PF-06882961
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
555.6
Solubility
DMSO: 125mg/mL (224.98mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C31H30FN5O4
SMILES
OC(C1=CC=C(N=C(CN2CCC(C3=NC(OCC4=CC=C(C#N)C=C4F)=CC=C3)CC2)N5C[C@H]6OCC6)C5=C1)=O
CAS Number
2230198-02-2
Target & IC50
Others
In Vitro
PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat[3].

Product References and Citations for PF-06882961, inhibitor

20th SCI/RSC Medicinal Chemistry Symposium.
20th SCI/RSC Medicinal Chemistry Symposium.
Mendez M, et al. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R). J Med Chem. 2019 Oct 23.
Mendez M, et al. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R). J Med Chem. 2019 Oct 23.
POSSIBLE SIDE EFFECTS AND RISKS OF THE STUDY DRUG AND PROCEDURES.
POSSIBLE SIDE EFFECTS AND RISKS OF THE STUDY DRUG AND PROCEDURES.

Other Notes

Small volumes of PF-06882961, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for PF-06882961 purchase

MBS5753677 is an inhibitor targeting PF-06882961.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000